DocGo Statistics
Total Valuation
DocGo has a market cap or net worth of $56.29 million. The enterprise value is $34.45 million.
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DocGo has 98.75 million shares outstanding. The number of shares has decreased by -9.46% in one year.
| Current Share Class | 98.75M |
| Shares Outstanding | 98.75M |
| Shares Change (YoY) | -9.46% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 2.67% |
| Owned by Institutions (%) | 42.50% |
| Float | 96.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 21.66 |
| PS Ratio | 0.17 |
| Forward PS | 0.18 |
| PB Ratio | 0.39 |
| P/TBV Ratio | 0.39 |
| P/FCF Ratio | 1.88 |
| P/OCF Ratio | 1.63 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 1.15 |
Financial Position
The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.23.
| Current Ratio | 2.26 |
| Quick Ratio | 2.13 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.98 |
| Interest Coverage | -45.20 |
Financial Efficiency
Return on equity (ROE) is -89.05% and return on invested capital (ROIC) is -55.58%.
| Return on Equity (ROE) | -89.05% |
| Return on Assets (ROA) | -16.57% |
| Return on Invested Capital (ROIC) | -55.58% |
| Return on Capital Employed (ROCE) | -59.59% |
| Weighted Average Cost of Capital (WACC) | 8.16% |
| Revenue Per Employee | $90,302 |
| Profits Per Employee | -$51,121 |
| Employee Count | 3,568 |
| Asset Turnover | 0.96 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, DocGo has paid $8.87 million in taxes.
| Income Tax | 8.87M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.73% in the last 52 weeks. The beta is 0.98, so DocGo's price volatility has been similar to the market average.
| Beta (5Y) | 0.98 |
| 52-Week Price Change | -78.73% |
| 50-Day Moving Average | 0.71 |
| 200-Day Moving Average | 1.14 |
| Relative Strength Index (RSI) | 38.19 |
| Average Volume (20 Days) | 1,406,987 |
Short Selling Information
The latest short interest is 5.91 million, so 5.99% of the outstanding shares have been sold short.
| Short Interest | 5.91M |
| Short Previous Month | 5.82M |
| Short % of Shares Out | 5.99% |
| Short % of Float | 6.15% |
| Short Ratio (days to cover) | 9.25 |
Income Statement
In the last 12 months, DocGo had revenue of $322.20 million and -$182.40 million in losses. Loss per share was -$1.84.
| Revenue | 322.20M |
| Gross Profit | 98.76M |
| Operating Income | -89.16M |
| Pretax Income | -187.50M |
| Net Income | -182.40M |
| EBITDA | -73.50M |
| EBIT | -89.16M |
| Loss Per Share | -$1.84 |
Full Income StatementBalance Sheet
The company has $51.02 million in cash and $29.18 million in debt, with a net cash position of $21.84 million or $0.22 per share.
| Cash & Cash Equivalents | 51.02M |
| Total Debt | 29.18M |
| Net Cash | 21.84M |
| Net Cash Per Share | $0.22 |
| Equity (Book Value) | 125.87M |
| Book Value Per Share | 1.46 |
| Working Capital | 84.91M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $34.45 million and capital expenditures -$4.54 million, giving a free cash flow of $29.91 million.
| Operating Cash Flow | 34.45M |
| Capital Expenditures | -4.54M |
| Depreciation & Amortization | 15.66M |
| Net Borrowing | -35.17M |
| Free Cash Flow | 29.91M |
| FCF Per Share | $0.30 |
Full Cash Flow StatementMargins
Gross margin is 30.65%, with operating and profit margins of -27.67% and -56.61%.
| Gross Margin | 30.65% |
| Operating Margin | -27.67% |
| Pretax Margin | -58.19% |
| Profit Margin | -56.61% |
| EBITDA Margin | -22.81% |
| EBIT Margin | -27.67% |
| FCF Margin | 9.28% |
Dividends & Yields
DocGo does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 9.46% |
| Shareholder Yield | n/a |
| Earnings Yield | -324.05% |
| FCF Yield | 53.13% |
Analyst Forecast
The average price target for DocGo is $2.38, which is 317.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.38 |
| Price Target Difference | 317.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
DocGo has an Altman Z-Score of 0.79 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.79 |
| Piotroski F-Score | 2 |
